Retrospective assessment of islet cell autoantibodies in pancreas organ donors

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1741-1742

  Diamantopoulos, Stavros ^a   Allende, Gloria ^a   Ferreira, Joseph M ^a   Ciancio, Gaetano ^a   Burke, George W ^a   Pugliese, Alberto ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1A2; PROTEIN TYROSINE PHOSPHATASE 1A2 ANTIBODY; UNCLASSIFIED DRUG; ICA512 AUTOANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; RECIPIENT; RETROSPECTIVE STUDY; SCHOOL CHILD; BLOOD; BLOOD GROUP ABO SYSTEM; CADAVER; DONOR; IMMUNOLOGY; PANCREAS ISLET; PANCREAS RESECTION;

ABO BLOOD-GROUP SYSTEM; AUTOANTIBODIES; CADAVER; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATECTOMY; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 56149101153     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0652     Document Type: Article

References (10)

1. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
2. Barker JM: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91:1210-1217, 2006
3. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
4. Burke GW, Ciancio G, Sollinger HW: Advances in pancreas transplantation. Transplantation 77:S62-S67, 2004
5. Gianani R, Putnam A, Still T, Yu L, Miao D, Gill RG, Beilke J, Supon P, Valentine A, Iveson A, Dunn S, Eisenbarth GS, Hutton J, Gottlieb P, Wiseman A: Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 91:1855-1861, 2006
6. In't Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, Pipeleers-Marichal M, Gorus F, Pipeleers D: Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400-2404, 2007
7. Burke GW, Ciancio G, Olson L, Roth D, Miller J: Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus- based immunosuppression. Transplant Proc 33:1681-1683, 2001
8. Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
9. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
10. Knip M, Karjalainen J, Akerblom HK, the Childhood Diabetes in Finland Study Group: Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. Diabetes Care 21:1670-1673, 1998